Galway, Ireland-based Perfuze developed Millipede 070 to address critical unmet needs in ischemic stroke treatment. It aims to remove clots rapidly and safely through a novel, unique catheter.
Millipede 070 has a unique design with a rib-and-recess surface architecture to improve navigability and reduce tip stiffness while maintaining durability. The design features superior deliverability and high procedural efficiency, enabling a more refined approach for restoring blood flow to the brain during endovascular thrombectomy procedures.
The company currently has enrollment underway for its MARRS pivotal clinical study to support future regulatory submissions.
“Perfuze aims to provide neurovascular interventionists with innovative thrombectomy solutions, to maximize the…